Stanford University
Showing 12,851-12,900 of 12,926 Results
-
Jiayan Zhou
Affiliate, Medicine - Med/Cardiovascular Medicine
BioI am a Senior Computational Genomics Scientist at the Palo Alto Veterans Institute for Research (PAVIR) and was previously a Postdoctoral Scholar and Research Associate leading the identification of genes responsible for cardiovascular disease in the Division of Cardiovascular Medicine, School of Medicine, Stanford University, and the VA Palo Alto Health Care System. My research focuses on population genetics and precision public health.
-
Maggie Zhou
Instructor, Medicine - Oncology
BioDr. Zhou is an Instructor in the Division of Oncology at Stanford University with an academic focus in sarcoma. She graduated from Yale University with a B.A. and double majored in economics and molecular, cellular, and developmental biology. She subsequently received her M.D. from Stanford University School of Medicine, where she completed her internal medicine residency and fellowship training.
Her research interests center around the development of novel therapeutics, understanding pathophysiology of rare sarcoma subtypes, and evaluating the utility of circulating tumor DNA for assessing disease response and detecting minimal residual disease. She has co-authored over 20 peer-reviewed publications, including in Clinical Cancer Research and Nature Cell, and is an active member of the Sarcoma Clinical Trial Working Group in the Hoosier Cancer Research Network. Her research has been supported by the Chinese American Hematologist and Oncologist Network and Sarcoma Alliance for Research through Collaboration. -
Margaret J. Zhou, MD, MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Margaret Zhou is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. She also holds an appointment as clinical assistant professor at Stanford University School of Medicine.
She specializes in therapeutic endoscopy with expertise in treating Barrett’s esophagus and disorders of the pancreas and bile duct. In particular, she offers advanced endoscopic interventions to prevent, detect, and manage gastrointestinal (GI) cancers. These interventions include endoscopic mucosal resection, endoscopic ablation, endoscopic retrograde cholangiopancreatography, and endoscopic ultrasound. She is also interested in the management of esophageal disorders such as gastroesophageal reflux disease.
Dr. Zhou has published widely on improving the detection of precancerous lesions and cancers of the GI tract. She is particularly interested in prevention, early detection, and outcomes in Barrett’s esophagus, esophageal cancer, and stomach cancer. In addition, she has published on new technologies and the use of artificial intelligence in GI. Her research has been published in multiple journals including Clinical Gastroenterology and Hepatology; Clinical and Translational Gastroenterology; and Cancer Epidemiology, Biomarkers & Prevention.
Dr. Zhou is an active member of multiple national GI societies. She currently serves on the American Gastroenterological Association (AGA) Clinical Guidelines Committee and AGA Trainee and Early Career Committee. She also serves as an Associate Editor for Evidence-Based GI, an American College of Gastroenterology (ACG) journal. -
Sa Zhou
Postdoctoral Scholar, Neurosurgery
BioSa Zhou, Ph.D., received her Ph.D. in Biomedical Engineering from The Hong Kong Polytechnic University. Her research focuses on person-centered cognitive and physical enhancement for aging-related neurological disorders - including stroke, Parkinson’s disease (PD), and Alzheimer’s disease (AD) - through the development of closed-loop brain-computer interface (BCI)-guided neuromodulation and rehabilitation robotics, as well as the investigation of brain structural and functional connectivity using multimodal neuroimaging and electrophysiology.
-
Wenhui Zhou
Adjunct Clinical Instructor, Radiology
BioWenhui was born in Southeast China and then immigrated to the San Francisco Bay Area as a teenager. He attended the University of California, Davis under a Regent Scholarship, and graduated with highest honors in Biochemistry and Molecular Biology. Wenhui subsequently pursued training in medicine and translational research in the Medical Scientist Training Program (MSTP) at Tufts University. In the Laboratory of Dr. Charlotte Kuperwasser, Wenhui studied the regulation and function of transcription factors in triple-negative breast cancer with the goal of improving cancer diagnosis and therapeutics. Additionally, he pursued clinical research examining image-guided ablative therapy as a front-line treatment option for renal cancer under the mentorship of Dr. Ronald Arellano at Massachusetts General Hospital. Outside of his clinical and academic interests, Wenhui enjoys food, taking walks, listening to NPR, and spending time with family and friends.
-
Zixia Zhou
Postdoctoral Scholar, Radiation Physics
BioZixia Zhou is a postdoctoral researcher at Department of Radiation Oncology, Stanford University. Before starting her postdoc, she received a Ph.D. degree in Biomedical Engineering in 2021 from Fudan University. She is interested in improving medical imaging quality in cost-effective manners with artificial intelligence. Broadly, her research focuses on high spatio-temporal ultrasound image reconstruction and high-dimensional data reduction and visualization.
-
Han Zhu
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Zhu is an Assistant Professor of Medicine whose clinical and research expertise focuses on cardio-oncology and cardio-immunology. She specializes in the cardiovascular care of patients undergoing therapies for cancer, with a particular focus on the effects of immunotherapies on the heart. She received a bioengineering degree from MIT, medical degree from Case Western Reserve University, and completed clinical cardiology fellowship and internal medicine residency training at Stanford University School of Medicine. Dr. Zhu’s laboratory focuses on myocarditis, cardiac inflammation, and the effects of cancer therapeutics on the cardiovascular system. Her current research employs clinical data, bio-banked samples, and in vivo/in vitro preclinical models in combination with single-cell technologies to study immune-based toxicities in the heart. Dr. Zhu's clinic sees cardio-oncology and cardio-immunology patients and her lab focuses on devising new methods for minimizing cardiovascular complications in the cancer and autoimmune patient populations.
-
Wenjuan Zhu
Postdoctoral Scholar, Cardiovascular Institute
BioPostdoctoral Fellow
-
Ying Zhu
Postdoctoral Scholar, Gastroenterology, Hepatology, and Nutrition
BioDr. Ying Zhu is a postdoctoral scholar in the Rosen Lab at Stanford University in the Department of Pediatrics, Division of Gastroenterology, Hepatology & Nutrition. She received her PhD in 2023 from the Friedman School of Nutrition Science and Policy at Tufts University. Her research studied the role of intestinal Acyl-CoA long-chain synthetase 5 in diet-induced obesity using inducible transgenic mouse model. Within the Rosen Lab, Dr. Zhu is focusing on intestine epithelial metabolic dysfunction in pediatric IBDs and chronic intestinal inflammation.
-
Lindsey Zimmerman
Affiliate, Psych/Public Mental Health & Population Sciences
BioLindsey Zimmerman, PhD, is a Clinical and Community Psychologist, and Implementation Scientist at the National Center for PTSD, Dissemination and Training Division of the Veterans Health Administration.
Dr. Zimmerman is principal investigator of National Institutes of Health (NIH) and Veterans Health Administration (VA) research that enlists participatory system dynamics to increase timely patient access to evidence-based pharmacotherapy and evidence-based psychotherapy for depression, PTSD, alcohol and opioid use disorder. See https://mtl.how/team
Active NIH Grants
Participatory System Dynamics vs Audit and Feedback: A Cluster Randomized Trial of Mechanisms Of Implementation Change to Expand Reach of Evidence-Based Addiction and Mental Health Care (R01DA046651)
The most common reasons Veterans seek VA addiction and mental health care is for help with opioid and alcohol misuse, depression and PTSD. Research evidence has established highly effective treatments that prevent relapse, overdose and suicide, but even with policy mandates, performance metrics, and electronic health records to fix the problem, these treatments may only reach 3-28% of patients. This study tests participatory business engineering methods to better meet the addiction and mental health needs of Veterans and the U.S. population.
Participatory System Dynamics for Evidence-Based Addiction and Mental Healthcare (R21DA042198)
Limited access and delays to high-quality, evidence-based mental health and addiction treatments can lead to patients getting too little or ineffective care and contribute to chronic patient impairment, relapse, and death by suicide or overdose. This study evaluates a system for resolving problems with patient flow and organization in health care systems, using electronic medical record systems and a high-level of input from healthcare leadership, frontline providers and patients.
Active VA Grants
Participatory System Dynamics vs Usual Quality Improvement: Is Staff Use of Simulation an Effective, Scalable and Affordable Way to Improve Timely Veteran Access to High-quality Mental Health Care? (I01HX002521)
Participatory system dynamics (PSD) helps improve quality with existing resources, critical in mental health and all VA health care. PSD uses learning simulations to improve staff decisions, showing how goals for quality can best be achieved given local resources and constraints. We aim to significantly increase the proportion of patients who start and complete evidence-based care, and determine the costs of using PSD for improvement.
National Responsibilities
2019 National Institutes of Health, Center for Scientific Review
Community Influences on Health Behavior (CIHB) Study Section
2019-present VA Quality Enhancement Research Initiative (QUERI)
QUERI/Health Services Research & Development, Scientific Merit Review Committee
2019-present Emory University
Prolonged Exposure Consultant Training Program Advisory Board
2018-present National Institutes of Health
Training Institute for Dissemination and Implementation Research in Health (TIDIRH)
Mental Health Faculty Mentor
2015-2017 National Institutes of Health Loan Repayment Program
National Institute of Mental Health Clinical Research Review Committee
Teaching Responsibilities
Quality Improvement and Systems of Care Competencies
Psychiatry & Behavioral Sciences Residency, Stanford University School of Medicine & VA Palo Alto Health Care System
Postdoctoral Research Fellowship Program Seminar
VA Palo Alto research centers of the National Center for PTSD (NCPTSD), Center for Innovation to Implementation (Ci2i), Mental Illness Research Education and Clinical Care (MIRECC), and War-related Illness and Injury Study Center (WRIISC).
Open Science Resources for the Modeling to Learn Simulation Learning Program are available on GitHub at https://mtl.how and https://mtl.how/demo -
Judith Zimmermann
Postdoctoral Scholar, Radiological Sciences Laboratory
BioI am a postdoctoral scholar focusing on advancing breast magnetic resonance imaging, advised by Dr. Brian Hargreaves at the Radiological Sciences Laboratory (RSL), Body Magnetic Resonance (BMR) Group. My research objectives are driven by the need for faster, more accessible breast cancer screening using MRI. Specifically, I want to advance methods for contrast-free imaging, as well as enabling MRI exams with the patient positioned supine, that is laying on their back. I work in close collaboration with clinicians at Stanford Clinics, and contribute to translating new techniques to clinical practice.
I received my PhD from the Department of Computer Science, Technical University of Munich in 2021, jointly with the CMR Lab at Stanford, advised by Dr. Daniel Ennis. My PhD work focused on four-dimensional flow magnetic resonance imaging. After completion of my PhD studies, and prior to joining Dr. Hargreaves' lab, I was with the Breast Imaging Research Group (Dr. Nola Hylton) at UCSF.
